Our technologies utilize ion exchange resin to form a drug resin complex. The drug is first dissolved in a solution removing variability due to crystalline structure. Next, the ion exchange process takes place as the resin is introduced to the liquid drug solution. The resulting drug resin particles possess enhanced properties that are exploited in further drug development technologies utilized by Spectrix. These technologies include, imparting controlled release membranes, pH dependent delivery, ultra-dilution, enhanced bioavailability or increased stability of a drug product.
These technologies result in pharmacokinetic profiles previously unavailable for the given indication or patient population. This strong technology platform and robust intellectual property allows for investment in drug products that are revolutionary within their class.